Summary

Background

BNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals are limited.

Matéria original

Anterior

Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19

Próxima

Spatial and temporal dynamics of SARS‐CoV‐2: Modeling, analysis and simulation